Education Library

Dirk Westermann, MD, discusses the timing of left ventricular unloading in VA ECMO patients at EuroPCR 2023.

Nikos Werner, MD, discusses best practices for high-risk percutaneous coronary interventions (HRPCI) at EuroPCR 2023.

Javier Escaned, MD, Nikos Werner, MD, Dirk Westermann, MD, and Vasileios Panoulas, MD, answer questions following the EuroPCR session “How to optimize high-risk patient outcome?”

Vasileios Panoulas, MD, discusses data regarding completeness of revascularization in high-risk PCI with mechanical circulatory support (MCS) at EuroPCR 2023.

Javier Escaned, MD, opens the session titled “How to optimize high-risk patient outcome?” at EuroPCR 2023. 

Fadi Al-Rashid, MD, discusses his publication on standard pre-procedural clinical workup for Protected PCI.

Jürgen Leick, MD, discusses his paper on optimizing patient selection in high-risk protected percutaneous coronary intervention.

Prof. Dr. Jan-Malte Sinning discusses optimal revascularization strategies during protected high-risk procedures with Impella® heart pumps.

Birgit Markus, MD, discusses data on the impact of Impella® heart pump support on hemodynamics and renal function in patients with cardiogenic shock.

Prof. Karim Ibrahim discusses his article describing best practices for handling high-risk patients in the cardiac catheterization laboratory.

Prof. Dr. Christophe Vandenbriele discusses his recently published paper on anticoagulation in patients undergoing Protected PCI procedures.

Prof. Christophe Vandenbriele, MD, urges caution and the need for context when drawing conclusions from retrospective analyses in critically ill patients with cardiogenic shock. 

Vasileios Panoulas, MD, discusses an individual patient data pooling from the PROTECT II RCT, PROTECT III, and RESTORE EF trials released at EuroPCR 2023.

This FAQ addresses thrombus formation and anticoagulation for blood-contacting medical devices, such as the Impella® heart pump.

Now Approved for Impella 5.5® with SmartAssist®